The chrome gleam of OmniCorp Tower pierced the smog-choked sky, a monument to progress – or so the ads chirped. Inside, Elias Vance, head of Cybernetics Division, surveyed the sterile lab. Rows of deactivated cyborgs lay on steel tables, their exposed neural interfaces shimmering under the fluorescent lights. Profit margins, not patient well-being, fueled Vance’s ambition. OmniCorp wasn't just selling